Professor Kenji Hamaoka
Kyoto Prefectural University of Medicine, Kyoto (Japan)
Potential of Proline-rich tyrosine kinase 2 (Pyk2) as a therapeutic target for Kawasaki disease.
Event: ESC Congress 2018
Topic: Cardiovascular Disease in Special Populations: Paediatric Cardiology
Session: Special populations
ESC 365 is supported by
